Robert B. Jenkins

Association of CDKN2A/B and MTAP deletions in adult-type diffuse gliomas.

Comparison of clinical, radiographic and genomic alterations between histologic and molecular glioblastoma, <i>IDH</i>-wildtype.

MRI Deep Learning for Differentiating Glioblastoma, IDH-Wildtype from Central Nervous System Diffuse Large B-cell Lymphoma.

Evaluating the current neuro-oncology capacity in Sub-Saharan Africa: A questionnaire-based survey.

Longitudinal Glioma Monitoring via Cerebrospinal Fluid Cell-Free DNA.

Switching Drivers: Epigenetic Rewiring to Genetic Progression in Glioma.

Dissecting the biology of gliomagenesis: Evaluating the interaction between <i>IDH</i> tumor mutation and germline variants.

Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomide.

Deep Learning MRI Models for the Differential Diagnosis of Tumefactive Demyelination versus <i>IDH</i> Wild-Type Glioblastoma.

Data from Longitudinal Glioma Monitoring via Cerebrospinal Fluid Cell-Free DNA

Supplemental Table 1 from Longitudinal Glioma Monitoring via Cerebrospinal Fluid Cell-Free DNA

Supplemental Table 2 from Longitudinal Glioma Monitoring via Cerebrospinal Fluid Cell-Free DNA

Supplementary Materials 1 from Longitudinal Glioma Monitoring via Cerebrospinal Fluid Cell-Free DNA

Supplemental Table 3 from Longitudinal Glioma Monitoring via Cerebrospinal Fluid Cell-Free DNA

PATH-82. Multivariate survival risk stratification in GBMs lacking necrosis and microvascular proliferation

Establishment of a brain tumor consortium of Africa: Advancing collaborative research and advocacy for brain tumors in Africa.

Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions.

Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions

Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas

Diffuse hemispheric glioma with H3-3B G34R mutation: Expanding the spectrum of histone H3 genes in diffuse hemispheric glioma, H3 G34-mutant.

SMARCAL1: Expanding the spectrum of genes associated with alternative lengthening of telomeres.

Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions

A noncoding single-nucleotide polymorphism at 8q24 drives <i>IDH1</i> -mutant glioma formation

A noncoding single-nucleotide polymorphism at 8q24 drives &lt;i&gt;IDH1&lt;/i&gt;-mutant glioma formation.

Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas:Guideline from the College of American Pathologists in Collaboration with the American Association of Neuropathologists, Association for Molecular Pathology, and Society for Neuro-Oncology

The immunogenetics of viral antigen response is associated with subtype-specific glioma risk and survival

Inherited genetics of adult diffuse glioma and polygenic risk scores-a review.

Mutations of FH and IDH may induce gliomagenesis by similar mechanisms.

Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study

Generative Adversarial Networks to Synthesize Missing T1 and FLAIR MRI Sequences for Use in a Multisequence Brain Tumor Segmentation Model.

Analysis of Regular and Random Soliton Gases in Integrable Dispersive Partial Differential Equations.

Acquisition of a University Confocal Laser Scanning Microscope System

Experimental Program to Stimulate Competitive Research in Wyoming

Wyoming Experimental Program to Stimulate Competitive Research - Phase A, Planning Phase

Fy 1980 Science Faculty Professional Development Program

Creation of a Data Bank on Ecological Reserves